VentriPoint Diagnostics Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VPTDF research report →
Price Chart
About the company
VentriPoint Diagnostics Ltd. (VPTDF) is a medical technology company dedicated to creating and bringing to market diagnostic tools for the global assessment of patients with cardiac conditions. The company's primary offering is the VentriPoint Medical System (VMS), an advanced medical imaging platform.
- CEO
- Hugh MacNaught
- IPO
- 2010
- Employees
- 3
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on VPTDF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $11.53M
- P/E
- -6.87
- PEG
- -0.08
- P/S
- 114.29
- P/B
- -4.39
- EV/EBITDA
- -28.22
- Div Yield
- 0.00%
- Gross Margin
- 89.55%
- Op Margin
- -1624.48%
- Net Margin
- -1568.50%
- ROE
- 56.40%
- ROIC
- 192.91%
Latest fiscal year · YoY change
- Revenue
- $179.78K+88.9%
- Gross Profit
- $118.59K+24.6%
- Op Income
- $-3,396,732
- Net Income
- $-3,197,633+35.0%
- EPS
- $-0.02+37.9%
- OCF Growth
- +54.1%
- FCF Growth
- +54.1%
- 52W High
- $0.14
- 52W Low
- $0.06
- 50D MA
- $0.07
- 200D MA
- $0.08
- Beta
- 0.04
- RSI (14)
- 40
- Avg Volume
- 120.68K
No earnings-call transcripts are available for VPTDF yet.
- Free Float
- 88.9%
- Shares Outstanding
- 187.66M
- Float Shares
- 166.75M
Our VPTDF coverage
Recent articles, reports, and earnings notes.
No research on VPTDF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VPTDF report →Ventripoint Provides Corporate Update and Announces Shareholder Videoconference Call
thenewswire.com · Oct 6
Ventripoint Announces Successful Completion of Annual Quality and Regulatory Audits
thenewswire.com · Sep 24
Ventripoint Closes First Tranche of Private Placement Financing and Engages Strategic Advisors to Accelerate Commercialization of VMS+™ Technology
thenewswire.com · Sep 8
UniDoc Health Signs MOU with Ventripoint Diagnostics to Evaluate Remote Cardiac Assessment and Screening Platform
accessnewswire.com · Aug 20
Ventripoint Expands Subscription Access for FDA-Cleared AI Cardiac Imaging
globenewswire.com · Aug 12
Ventripoint Diagnostics Announces Cancellation and Re-Grant of Options, Grant of Annual Incentive Options and Private Placement
thenewswire.com · Aug 7
UniDoc Health and Ventripoint Diagnostics Sign MOU to Evaluate Scalable Remote Cardiac Assessment and Screening Platform
thenewswire.com · Aug 5
Ventripoint Strengthens Board with Appointment of MedTech Executive and Commercialization Leader Dr. Philip Toleikis
thenewswire.com · Jul 29
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.